{ "cik": 1001316, "cik_padded": "0001001316", "entityName": "TG THERAPEUTICS, INC.", "fiscal_years": [ { "accn": "0001437749-26-006133", "filed": "2026-02-27", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 214000.0, "cash": 79148000.0, "eps_diluted": 2.77, "free_cash_flow": -24986000.0, "net_income": 447179000.0, "operating_cash_flow": -24772000.0, "operating_income": 123324000.0, "revenue": 616287000.0, "stockholders_equity": 648020000.0, "total_assets": 1063253000.0, "total_liabilities": 415233000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.640771889756489, "net_margin": 0.7256018705570619, "operating_margin": 0.20010806653393629, "revenue_growth_yoy": 0.8731899916110443, "roa_avg2y": 0.5450268534616985, "roa_period_end": 0.42057628805185593, "roe_avg2y": 1.0275441644147871, "roe_period_end": 0.690069750933613 } }, { "accn": "0001437749-26-006133", "filed": "2026-02-27", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 45000.0, "cash": 179894000.0, "eps_diluted": 0.15, "free_cash_flow": -40562000.0, "net_income": 23383000.0, "operating_cash_flow": -40517000.0, "operating_income": 41929000.0, "revenue": 329004000.0, "stockholders_equity": 222364000.0, "total_assets": 577690000.0, "total_liabilities": 355326000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.5979475094889461, "net_margin": 0.07107208422997896, "operating_margin": 0.1274422195474827, "revenue_growth_yoy": 0.4080338266384778, "roa_avg2y": 0.05154544863365874, "roa_period_end": 0.04047672627187592, "roe_avg2y": 0.12214717420716387, "roe_period_end": 0.10515641021028584 } }, { "accn": "0001437749-26-006133", "filed": "2026-02-27", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 0.0, "cash": 92933000.0, "eps_diluted": 0.09, "free_cash_flow": -31413000.0, "net_income": 12672000.0, "operating_cash_flow": -31413000.0, "operating_income": 20633000.0, "revenue": 233662000.0, "stockholders_equity": 160502000.0, "total_assets": 329587000.0, "total_liabilities": 169085000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 1.0534759691468019, "net_margin": 0.054232181527163165, "operating_margin": 0.08830276210937166, "revenue_growth_yoy": 82.90017953321365, "roa_avg2y": 0.04844416324673761, "roa_period_end": 0.038448118402728264, "roe_avg2y": 0.11567901629018344, "roe_period_end": 0.07895228719891341 } }, { "accn": "0001437749-26-006133", "filed": "2026-02-27", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 14000.0, "cash": 102304000.0, "eps_diluted": -1.65, "free_cash_flow": -176184000.0, "net_income": -223812000.0, "operating_cash_flow": -176170000.0, "operating_income": -218316000.0, "revenue": 2785000.0, "stockholders_equity": 58587000.0, "total_assets": 193572000.0, "total_liabilities": 134985000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.304009421885401, "revenue_growth_yoy": -0.5836447899536552, "roa_avg2y": -0.7809197820659769, "roa_period_end": -1.1562209410451925, "roe_avg2y": -1.513572732805843, "roe_period_end": -3.820164882994521 } }, { "accn": "0001558370-23-002610", "filed": "2025-03-03", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 401000.0, "cash": 298887000.0, "eps_diluted": -2.63, "free_cash_flow": -296035000.0, "net_income": -348101000.0, "operating_cash_flow": -295634000.0, "operating_income": -344770000.0, "revenue": 6689000.0, "stockholders_equity": 237153000.0, "total_assets": 379629000.0, "total_liabilities": 142476000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6007767137670618, "roa_avg2y": -0.6925515607234268, "roa_period_end": -0.9169504964057014, "roe_avg2y": -0.9202898071785571, "roe_period_end": -1.4678330023233945 } }, { "accn": "0001558370-22-002617", "filed": "2024-02-29", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 357000.0, "cash": 553439000.0, "eps_diluted": -2.42, "free_cash_flow": -214864000.0, "operating_cash_flow": -214507000.0, "operating_income": -273594000.0, "stockholders_equity": 519350000.0, "total_assets": 625642000.0, "total_liabilities": 106292000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio" }, "ratios": { "leverage": 0.2046635217098296 } }, { "accn": "0001558370-22-002617", "filed": "2022-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 131000.0, "cash": 112637000.0, "free_cash_flow": -132937000.0, "operating_cash_flow": -132806000.0, "operating_income": -169055000.0, "total_assets": 163014000.0, "total_liabilities": 124399000.0 }, "period_end": "2019-12-31", "ratios": {} }, { "accn": "0001558370-21-002149", "filed": "2021-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 90000.0, "cash": 41958000.0, "free_cash_flow": -129015000.0, "operating_cash_flow": -128925000.0, "operating_income": -174400000.0, "total_assets": 83616000.0, "total_liabilities": 59580000.0 }, "period_end": "2018-12-31", "ratios": {} }, { "accn": "0001558370-20-001897", "filed": "2020-03-02", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2000.0, "cash": 56718000.0, "free_cash_flow": -93762000.0, "operating_cash_flow": -93760000.0, "operating_income": -118712000.0, "total_assets": 97381000.0, "total_liabilities": 30388000.0 }, "period_end": "2017-12-31", "ratios": {} }, { "accn": "0001654954-19-002189", "filed": "2019-03-01", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "operating_income": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 344000.0, "cash": 25031000.0, "operating_income": -78969000.0, "total_assets": 54781547.0, "total_liabilities": 18913745.0 }, "period_end": "2016-12-31", "ratios": {} }, { "accn": "0001144204-14-014207", "filed": "2014-03-07", "fiscal_year": 2013, "form": "10-K", "fundamental_units": { "net_income": "USD" }, "fundamentals": { "net_income": -20478210.0 }, "period_end": "2013-12-31", "ratios": {} }, { "accn": "0001144204-14-014207", "filed": "2014-03-07", "fiscal_year": 2012, "form": "10-K", "fundamental_units": { "net_income": "USD", "operating_cash_flow": "USD", "stockholders_equity": "USD" }, "fundamentals": { "net_income": -18072719.0, "operating_cash_flow": -5187964.0, "stockholders_equity": 15550301.0 }, "period_end": "2012-12-31", "ratio_units": { "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "roe_avg2y": -1.4357773016230264, "roe_period_end": -1.162210236316326 } }, { "accn": "0001144204-13-016691", "filed": "2013-03-21", "fiscal_year": 2011, "form": "10-K", "fundamental_units": { "net_income": "USD", "stockholders_equity": "USD" }, "fundamentals": { "net_income": -853074.0, "stockholders_equity": 9624521.0 }, "period_end": "2011-12-31", "ratio_units": { "roe_period_end": "ratio" }, "ratios": { "roe_period_end": -0.08863547598888298 } } ], "latest_filing": { "accn": "0001437749-26-006133", "filed": "2026-02-27", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001001316.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001001316.json" }, "ticker": "TGTX" }